Trump signs executive actions to boost domestic drug manufacturing and oversight of gain-of-function research, raising concerns over potential higher costs and shortages.
U.S. Treasury Secretary defends Trump's economic agenda of tariffs, tax cuts, and deregulation as a strategy to attract global investment, despite skepticism from business leaders and economists.
Trump signs executive actions to boost domestic drug manufacturing and oversight of gain-of-function research, raising concerns over potential higher costs and shortages.
U.S. Treasury Secretary defends Trump's economic agenda of tariffs, tax cuts, and deregulation as a strategy to attract global investment, despite skepticism from business leaders and economists.